Health Condition 1: K80-K87- Disorders of gallbladder, biliary tract and pancreas
Conditions
Interventions
Intervention1: 50mg/kg of 10% MgSO4 diluted in 100 ml 0.9% normal saline: 50mg/kg of 10% MgSO4 diluted in 100 ml 0.9% normal saline will be instilled in the subdiaphragmatic space over 20 minutes afte
Sponsors
PGIMER CHANDIGARH
Eligibility
Inclusion criteria
Inclusion criteria: ) Any gender 2) 18 – 65 years of age 3) ASA-I and II patients
Exclusion criteria
Exclusion criteria: Patient refusal to participate in the study 2) Conversion to open cholecystectomy 3) Pre-existing neurological or psychiatric illness which precludes giving an informed consent 4) Pre-existing active cardiac or renal impairment ( Creatinine level > 1.5 times of normal value ) and chronic disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1)To evaluate the analgesic efficacy of intraperitoneal magnesium sulphate in the prevention of postoperative pain in first 24 hours after surgery among patients undergoing elective laparoscopic cholecystectomyTimepoint: start of surgery to 48 hours after surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) To observe the incidence of postoperative pain 2) To evaluate requirement of total dose of analgesic after surgery 3) To observe the incidence of postoperative nausea and vomiting 4) To observe the effect on emergence time 5) To observe any postoperative adverse events related to magnesium sulfate Timepoint: start of surgery to 48 hours after surgery | — |
Countries
India
Contacts
Public ContactDivya dahiya
PGIMERChandigarh
Outcome results
None listed